NOS2 and idiopathic pulmonary fibrosis: Taken together, these results suggest that EVZO has an anti-inflammatory effect by regulating the expression of iNOS and COX-2, as well as a decrease in lipid peroxidation products induced in a BLM-induced IPF model.